Epidemiological features and financial loss due to clinically diagnosed Haemorrhagic septicemia in bovines in Karnataka, India
KRISHI: Publication and Data Inventory Repository
View Archive InfoField | Value | |
Title |
Epidemiological features and financial loss due to clinically diagnosed Haemorrhagic septicemia in bovines in Karnataka, India
Not Available |
|
Creator |
Govindaraj G
Krishnamoorthy P Nethrayini KR Shalini R Rahman H |
|
Subject |
Haemorrhagic Septicemia Endemicity Mortality Morbidity Case fatality Financial loss
|
|
Description |
Not Available
The epidemiological features and financial losses due to Haemorrhagic Septicemia (HS) in bovines were studied in Karnataka state using the primary data collected from 133 clinically diagnosed HS affected farms. The various losses due to HS and the Benefit- Cost ofthe vaccination programme in cattle and water buffaloes were studied using mathematical models. The number of HS outbreaks were higher during the year 2002 and peaked during 2005 and thereafter declined due to targeted vaccination against HS. The morbidity and mortality risks were lower in large farms than medium and small farms, and lower in indigenous cattle compared to high yielding crossbred cattle and water buffaloes. The disease occurrence was more in in-milk animals causing serious economic loss to the farmers. Most outbreaks were observed during monsoon season, though the disease was prevalent throughout the year. The mean milk loss per animal was $2, $11 and $50 in indigenous cattle, water buffaloes and crossbred cattle, respectively. In the case of draught animals, the average effective draught power was unavailable for 1.2 days/outbreak resulting in a loss of $5 per affected oxen. The treatment and extra labor expenses incurred per animal were $24 and $7, respectively. The average loss per animal due to mortality loss was $275, $284 and $415 in case of indigenous cattle, water buffaloes and crossbred cattle, respectively. The projected loss for the state of Karnataka were $23.89, $17.92 and $11.95 million under high, medium and low HS incidence scenarios, respectively. The Benefit Cost Analysis (BCA) of the vaccination against HS has been estimated at 5.97:1, 4.48:1 and 2.98:1 under high, medium and low incidence scenarios, respectively. The results highlight the important epidemiological features and financial losses to the affected households and the state of Karnataka. Not Available |
|
Date |
2018-09-19T06:57:10Z
2018-09-19T06:57:10Z 2017-05-31 |
|
Type |
Research Paper
|
|
Identifier |
Not Available
0167-5877 http://krishi.icar.gov.in/jspui/handle/123456789/7001 |
|
Language |
English
|
|
Relation |
Not Available;
|
|
Publisher |
Elsevier Publications
|
|